Newly emerged Procalcitonin is gaining attention as a potential marker of inflammation. Does it is really good marker for all type of systemic inflammation particularly for impending cardiovascular diseases?
Procalcitonin may be a better choice, though it is more expensive than CRP.
unfortunately, none of these studies can give a correct assessment of the degree of inflammation of the patient
hsCRP, among others is remaining a credible inflammatory marker in CV disease .
Procalcitonin, it is needed further
evidence .
CRP has recently been demonstrated to be a risk marker for inflammation and cardiovascular disease. Furthermore, it has classically been considered a widespread marker of inflammation. Procalcitonin also seems to be a proinflammatory marker but it probably has less evidence beyond it
I agree with you Andrei. There are no exclusivities or boundaries here. Biomarkers working on a complementary basis.
I do not think they can be compared since procalcitonin is used more in inflammation associated with serious infections that stimulate its greater production in the C cells of the thyroid and in other extrathyroidal tissues.
While PRC may rise in sepsis and other non-septic pathologies such as immunological.
and speaking exclusively of cardiovascular alterations the ultrasensitive PCR has greater affinity with said problems
http://www.revcocmed.sld.cu/index.php/cocmed/article/view/978/621
Article [High sensitivity C protein as an independent risk factor in...